CD4+ T CELL PROFILES IN IDDM
CD4+ T CELL PROFILES IN IDDM
批准号:
7468454
负责人:
GERALD T NEPOM
金额:
$26.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-06-30
关键词:
AccountingAffinityAllelesAntigensAttentionAutoantibodiesAutoantigensAutoimmune DiabetesAutoimmunityAvidityB-LymphocytesBindingCD4 Positive T LymphocytesCell DeathCell SeparationCellsClassClinicalDataDiabetes MellitusDiseaseDisease ProgressionDown-RegulationEpitopesEventHLA-DR4 AntigenHumanImmuneImmunityImmunologicsIndividualInsulin-Dependent Diabetes MellitusLigandsMeasuresMediatingMonitorNumbersOnset of illnessPathogenesisPathway interactionsPatientsPeptide/MHC ComplexPeripheralPersonal SatisfactionPhasePhenotypePopulationPopulation StudyPrevalenceProliferatingPropertyProteinsRefractoryRegulationResearch PersonnelResistanceRiskScreening procedureSignal TransductionSpecificityStagingStimulusT memory cellT-Cell ActivationT-LymphocyteT-Lymphocyte EpitopesTCR ActivationTechniquesTestingautoreactive T cellbasecohortdensityearly onsethuman subjectinterestisletnew technologyperipheral bloodpre-clinicalprogramsresponsetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A major determinant of CD4+ T cell activation and response is the strength of signal mediated by the trimolecular MHC-peptide-TCR interaction. This strength of signal is dependent on the density and duration of trimolecular interactions, and can be measured in terms of "functional avidity" for individual T cells. New technologies using MHC tetramers are now available to quantify functional avidity in a polyclonal T cell population, and we propose to use these techniques to evaluate the antigen-specific CD4+ T cell response in autoimmune diabetes. We hypothesize that high avidity recognition of multiple islet autoantigens correlates with disease progression or earlier disease onset. We predict that epitope spreading and high avidity responses fail to occur in subjects with non-progressive forms of islet autoimmunity, such as subjects with only a single islet autoantibody. At-risk and LADA cohorts in this program project will be compared to T1D subjects, and integrated with the autoantibody progression studies in Project 2. we will also test the hypothesis that autoreactive T cells may persist by becoming refractory to down-regulation, through the analysis of tetramer-sorted cells challenged with a variety of costimulatory or regulatory signals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune Tolerance Network
-
批准号:10469778
-
项目类别:
-
资助金额:$322.98万
-
财政年份:2021
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10493548
-
项目类别:
-
资助金额:$483.12万
-
财政年份:2021
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10471497
-
项目类别:
-
资助金额:$450.0万
-
财政年份:2021
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10397200
-
项目类别:
-
资助金额:$1979.33万
-
财政年份:2021
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10319233
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2020
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:9221236
-
项目类别:
-
资助金额:$2944.8万
-
财政年份:2014
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:8634324
-
项目类别:
-
资助金额:$3033.19万
-
财政年份:2014
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10331451
-
项目类别:
-
资助金额:$125.51万
-
财政年份:2014
-
负责人:GERALD T NEPOM
-
依托单位:
Immune Tolerance Network
-
批准号:10116129
-
项目类别:
-
资助金额:$2955.03万
-
财政年份:2014
-
负责人:GERALD T NEPOM
-
依托单位:
Checkpoints and Autoimmune Homeostasis in T1D
-
批准号:7686453
-
项目类别:
-
资助金额:$68.9万
-
财政年份:2008
-
负责人:GERALD T NEPOM
-
依托单位:
Checkpoints and Autoimmune homeostasis in T1D
-
批准号:7197629
-
项目类别:
-
资助金额:$133.22万
-
财政年份:2006
-
负责人:GERALD T NEPOM
-
依托单位:
CD4+ T CELL PROFILES IN IDDM
-
批准号:6916758
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2005
-
负责人:GERALD T NEPOM
-
依托单位:
MHC tetramers for epitopes of B anthracis PA
-
批准号:6883234
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2004
-
负责人:GERALD T NEPOM
-
依托单位:
MHC tetramers for epitopes of B anthracis PA
-
批准号:6763899
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2004
-
负责人:GERALD T NEPOM
-
依托单位:
Treatment/Type 1 Diabetes/hGAD65 Altered Peptide Ligand
-
批准号:6575447
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2002
-
负责人:GERALD T NEPOM
-
依托单位:
Treatment/Type 1 Diabetes/hGAD65 Altered Peptide Ligand
-
批准号:6665526
-
项目类别:
-
资助金额:$43.88万
-
财政年份:2002
-
负责人:GERALD T NEPOM
-
依托单位:
Checkpoints and Autoimmune Homeostasis in T1D
-
批准号:8331004
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2001
-
负责人:GERALD T NEPOM
-
依托单位:
ALLELE SPECIFIC TRANSCRIPTIONAL CONTROL OF HLA DQ EXPRESSION
-
批准号:6564322
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2001
-
负责人:GERALD T NEPOM
-
依托单位:
PEPTIDE-BASED IMMUNOMODULATION OF IDDM
-
批准号:6349093
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2000
-
负责人:GERALD T NEPOM
-
依托单位:
PEPTIDE-BASED IMMUNOMODULATION OF IDDM
-
批准号:6201973
-
项目类别:
-
资助金额:$21.25万
-
财政年份:1999
-
负责人:GERALD T NEPOM
-
依托单位:
海外基金